A randomized, double-blind, placebo-controlled, mechanistic trial on the safety, tolerability and pharmacodynamics of ninerafaxstat in patients with angina and chronic coronary syndrome
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Turku University Hospital, Turku (Finland)
8 More presentations in this session
Miss R. Hua (Nanjing, CN)
Professor E. Ramacciotti (Santo Andre, BR)
Doctor K. Ueno (Oita, JP)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
